Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / GENOMICS IMMUN
-
Number of holders
-
87
-
Total 13F shares, excl. options
-
2,042,497
-
Shares change
-
+166,678
-
Total reported value, excl. options
-
$103,546,388
-
Value change
-
+$8,436,124
-
Number of buys
-
45
-
Number of sells
-
-19
-
Price
-
$50.71
Significant Holders of ISHARES TR - GENOMICS IMMUN (IDNA) as of Q3 2021
92 filings reported holding IDNA - ISHARES TR - GENOMICS IMMUN as of Q3 2021.
ISHARES TR - GENOMICS IMMUN (IDNA) has 87 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2,042,497 shares
.
Largest 10 shareholders include BANK OF AMERICA CORP /DE/ (317,515 shares), UBS Group AG (229,467 shares), Wharton Business Group, LLC (160,995 shares), Thrivent Financial for Lutherans (142,036 shares), Wealthcare Advisory Partners LLC (120,074 shares), LPL Financial LLC (101,069 shares), RETIREMENT CAPITAL STRATEGIES (85,387 shares), MORGAN STANLEY (72,555 shares), Sharkey, Howes & Javer (64,896 shares), and Principle Wealth Partners LLC (53,474 shares).
This table shows the top 87 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.